Skip to content

Obesity-hypoventilation in Metabolic Syndrom Patients

Prevalence of Obesity-hypoventilation Syndrome in Patients With Metabolic Syndrome.

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04839419
Enrollment
400
Registered
2021-04-09
Start date
2020-08-01
Completion date
2025-08-01
Last updated
2023-11-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Capnography, Metabolic Syndrome, Obesity Hypoventilation Syndrome

Brief summary

The purpose of the study is to determined the prevalence of obesity-hypoventilation syndrome in patients with metabolic syndrom.

Detailed description

After being informed about the study and potential risks, patient agreed to participate and undergo : a functional respiratory exploration, an arterial blood gas analyze, and a polygraphy coupled with a capnography during the same night.

Interventions

None listed

Sponsors

SOS Oxygene Mediterranee
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* BMI\>30 kg/m2 * no treatment with CPAP nor NIV

Exclusion criteria

* obstructive respiratory disease * non-treated cardiac dysfunction

Design outcomes

Primary

MeasureTime frameDescription
CapniaUp to one mont after inclusionArterial pression in CO2 and transcutaneous pression in CO2
Arterial pression in CO2At the inclusionPaCO2

Secondary

MeasureTime frameDescription
somnolenceAt the inclusionEPWORTH questionnaire; Minimum = 0; Maximum = 24, Higher score means a worth outcome
Physical activity levelAt the inclusionRicci&Gagnon questionnaire, Minimum = 9; Maximum = 45, Higher score means a worth outcome
Arterial blood bicarbonatesAt the inclusionHCO3-
BMIAt the inclusionbody mass index
HemoglobinAt the inclusionHb
obstructive sleep apnea itemsUp to one mont after inclusionApnea-hypopnea index
Night Oxygen saturationUp to one mont after inclusionSpO2
Arterial blood gasesAt the inclusionpH
Arterial pression in oxygenAt the inclusionPaO2

Countries

France

Contacts

Primary ContactDelphine Delample, PhD
d.delample@sosoxygene.com0612155648

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026